Signal‐regulatory protein α from the NOD mouse binds human CD47 with an exceptionally high affinity – implications for engraftment of human cells
Open Access
- 29 July 2014
- journal article
- Published by Wiley in Immunology
- Vol. 143 (1) , 61-67
Abstract
Summary: One common way to study human leucocytes and cancer cells in an experimental in vivo situation is to use mice that have been genetically engineered to lack an immune system and prevent human cell rejection. These mice lack CD132 and either RAG2 or the catalytic subunit of the DNA‐dependent protein kinase, to make the mice deficient in lymphocytes and natural killer cells. The NOD mouse strain provides a better background for engraftment than other strains due to stronger engagement of the signal‐regulatory protein‐α (SIRPα) inhibitory receptor with human CD47 (hCD47) resulting in a ‘don't‐eat‐me’ signal. To determine the molecular parameters that determine this major functional effect in the NOD mouse we measured the affinity of hCD47 for SIRPα from various mouse strains. Human CD47 bound SIRPα from the NOD mouse with an affinity 65 times greater than SIRPα from other mouse strains. This is due mainly to the NOD SIRPα lacking two amino acids in domain 1 compared with other mouse strains. Remarkably the SIRPα(NOD) binds hCD47 with 10 times the affinity of the syngeneic hCD47/hSIRPα interaction. This affinity is outside the normal range for affinities for leucocyte surface protein interactions and raises questions as to what is the optimal affinity of this interaction for engraftment and what other xenogeneic interactions involved in homeostasis may also not be optimal.Keywords
Funding Information
- Medical Research Council (G9826026)
This publication has 33 references indexed in Scilit:
- Dissection of Agonistic and Blocking Effects of CD200 Receptor AntibodiesPLOS ONE, 2013
- Structures of CD200/CD200 Receptor Family and Implications for Topology, Regulation, and EvolutionStructure, 2013
- Disruption of SIRPα signaling in macrophages eliminates human acute myeloid leukemia stem cells in xenograftsJournal of Experimental Medicine, 2012
- The CD47–SIRPα pathway in cancer immune evasion and potential therapeutic implicationsCurrent Opinion in Immunology, 2012
- CD47–signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destructionProceedings of the National Academy of Sciences, 2011
- Transgenic expression of human signal regulatory protein alpha in Rag2−/−γc−/−mice improves engraftment of human hematopoietic cells in humanized miceProceedings of the National Academy of Sciences, 2011
- Functional CD47/signal regulatory protein alpha (SIRPα) interaction is required for optimal human T- and natural killer- (NK) cell homeostasis in vivoProceedings of the National Academy of Sciences, 2011
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem CellsCell, 2009
- The Counterbalance Theory for Evolution and Function of Paired ReceptorsImmunity, 2008
- Lack of CD47 on nonhematopoietic cells induces split macrophage tolerance to CD47nullcellsProceedings of the National Academy of Sciences, 2007